Seasonal Allergic Rhinitis: Diagnosis and Management

Uniqcret doctor knowledgesINMEDINMED RS
On this page

Definition

Seasonal allergic rhinitis (SAR) is an IgE-mediated inflammation of the nasal mucosa triggered by airborne allergens present during specific seasons — commonly pollen from trees, grasses, and weeds.


Pathophysiology

  • Sensitization: Initial exposure to allergen → IgE production → binds to mast cells.
  • Re-exposure: Allergen cross-links IgE → mast cell degranulation → release of histamine, leukotrienes, prostaglandins.
  • Early-phase response (minutes): Sneezing, itching, rhinorrhea.
  • Late-phase response (hours): Nasal congestion from inflammatory cell infiltration.

Epidemiology

  • Common in children and young adults.
  • Prevalence up to 20–30% worldwide.
  • Family history of atopy increases risk.

Clinical Presentation

Symptoms (worsen during specific seasons):

  • Sneezing
  • Nasal congestion
  • Clear watery rhinorrhea
  • Nasal itching
  • Ocular symptoms (itchy, watery, red eyes)

Triggers:

  • Tree pollens (spring)
  • Grass pollens (summer)
  • Weed pollens (fall)

Diagnosis

1. History — seasonal pattern, symptom triggers, family history of allergy.2. Physical examination:

  • Allergic shiners (dark infraorbital circles)
  • Pale, bluish, edematous nasal mucosa
  • Clear nasal discharge
  • Dennie–Morgan folds under lower eyelids
  • Mouth breathing in severe cases

3. Investigations (if needed):

  • Skin prick test or serum-specific IgE to identify allergens.
  • Nasal cytology (eosinophils).
  • Rule out sinusitis, vasomotor rhinitis, or nasal polyps.

Management

A. Allergen Avoidance

  • Environmental control: Monitor pollen counts, stay indoors during peak hours (early morning, windy days), use air conditioning with HEPA filters.
  • Personal protection: Sunglasses outdoors, mask if mowing lawn, shower + change clothes after outdoor exposure.

B. Pharmacotherapy

First-line: Intranasal Corticosteroids (most effective)

Used daily, correct spray technique (slightly outward from nasal septum).Start 1–2 weeks before allergen season for prevention.

DrugUsual Adult DoseMax DoseNotes
Fluticasone propionate (Flixonase®) 50 mcg/spray1–2 sprays/nostril OD200 mcg/dayOnset 6–12 h, peak effect ~3 days
Mometasone furoate (Nasonex®) 50 mcg/spray2 sprays/nostril OD or 1 spray/nostril BID200 mcg/dayVery low systemic absorption
Budesonide (Rhinocort®) 64 mcg/spray1 spray/nostril BID or 2 sprays/nostril OD256 mcg/dayPregnancy category B — safe option

💡 Pediatric dosing: usually half adult dose; always check product-specific recommendations.

Adjunctive: Oral Second-Generation Antihistamines

Rapid onset (1–3 h), best for sneezing, itching, rhinorrhea.Minimal effect on congestion compared to nasal steroids.

DrugAdult DosePediatric DoseNotes
Cetirizine10 mg PO OD5–10 mg PO OD (≥2 yrs)Mild sedation possible
Loratadine10 mg PO OD5–10 mg PO OD (≥2 yrs)Non-sedating
Fexofenadine120 mg PO OD or 60 mg PO BID30–60 mg PO BID (≥2 yrs)Non-sedating, fast onset

Adjunctive: Intranasal Antihistamines

Faster onset than steroids (~15–30 min).Good for as-needed relief or in combo with steroids for severe SAR.

DrugAdult DosePediatric DoseNotes
Azelastine 137 mcg/spray1–2 sprays/nostril BID1 spray/nostril BID (≥5 yrs)May cause bitter taste, drowsiness
Olopatadine 665 mcg/spray2 sprays/nostril BIDNot for <6 yrsGood ocular + nasal symptom control

Adjunctive: Ocular Antihistamine/Mast Cell Stabilizer Drops

For allergic conjunctivitis symptoms.

DrugDoseNotes
Olopatadine 0.1%1 drop/eye BIDFast relief, long duration
Ketotifen 0.025%1 drop/eye BIDOTC in many countries

Combination Therapy

  • Fluticasone + Azelastine (Dymista®) 50 mcg/137 mcg per spray:
    • Dose: 1 spray/nostril BID
    • Combines anti-inflammatory + rapid antihistamine effect.
    • Useful in severe or uncontrolled SAR despite monotherapy.

C. Saline Nasal Irrigation

  • Isotonic (0.9%) or hypertonic (1.5–3%) saline rinse.
  • Dose: 50–250 mL per nostril OD–BID via squeeze bottle or neti pot.
  • Use before steroid spray to improve drug penetration.

D. Allergen Immunotherapy (AIT)

  • Subcutaneous (SCIT):
    • Weekly build-up injections → monthly maintenance.
    • Duration: 3–5 years.
  • Sublingual (SLIT):
    • Daily allergen tablet/drop under tongue.
    • Start 3–4 months before season, continue through exposure period.

Indicated for:

  • Moderate–severe SAR not controlled with optimal pharmacotherapy
  • Patient preference to reduce long-term drug use
  • Specific IgE-proven allergen sensitization

Stepwise Summary Table (Adult)

StepTherapyExample Dose
1Intranasal corticosteroidFluticasone 1–2 sprays/nostril OD
2+ Oral antihistamineCetirizine 10 mg PO OD
3+ Intranasal antihistamineAzelastine 1 spray/nostril BID
4+ Ocular drops if neededOlopatadine 1 drop/eye BID
5Consider AITSCIT monthly or SLIT daily

Prognosis

  • SAR is not life-threatening but can impair quality of life, school/work performance, and predispose to asthma exacerbations.
  • Good control is achievable with consistent treatment and avoidance strategies.
0
Message for International and Thai ReadersUnderstanding My Medical Context in ThailandRead more →Message for International and Thai ReadersUnderstanding My Broader Content Beyond MedicineRead more →

Comments

No comments yet. Be the first to share your thoughts.

Sign in to comment